WELL Health Technologies (TSE:WELL) Price Target Cut to C$6.50 by Analysts at Scotiabank

WELL Health Technologies (TSE:WELLFree Report) had its target price reduced by Scotiabank from C$7.00 to C$6.50 in a research report sent to investors on Wednesday,BayStreet.CA reports. They currently have an outperform rating on the stock.

Separately, CIBC upgraded shares of WELL Health Technologies from a “neutral” rating to an “outperform” rating in a report on Wednesday, December 3rd. Six research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of C$7.35.

View Our Latest Research Report on WELL Health Technologies

WELL Health Technologies Trading Up 3.8%

TSE:WELL opened at C$4.10 on Wednesday. The stock has a market cap of C$1.04 billion, a price-to-earnings ratio of -45.56, a PEG ratio of -1.93 and a beta of 0.49. The company has a debt-to-equity ratio of 46.79, a quick ratio of 1.02 and a current ratio of 1.14. WELL Health Technologies has a 1 year low of C$3.58 and a 1 year high of C$6.36. The business has a fifty day moving average of C$4.02 and a 200-day moving average of C$4.52.

WELL Health Technologies (TSE:WELLGet Free Report) last posted its quarterly earnings data on Thursday, November 6th. The company reported C$0.16 earnings per share for the quarter. The business had revenue of C$364.60 million during the quarter. WELL Health Technologies had a net margin of 7.67% and a return on equity of 8.74%. Equities analysts predict that WELL Health Technologies will post 0.3000698 earnings per share for the current year.

WELL Health Technologies Company Profile

(Get Free Report)

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.

Recommended Stories

Analyst Recommendations for WELL Health Technologies (TSE:WELL)

Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.